Correlation Between Faron Pharmaceuticals and Ashtead Technology

Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Ashtead Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Ashtead Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Ashtead Technology Holdings, you can compare the effects of market volatilities on Faron Pharmaceuticals and Ashtead Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Ashtead Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Ashtead Technology.

Diversification Opportunities for Faron Pharmaceuticals and Ashtead Technology

0.79

Correlation Coefficient

Faron Pharmaceuticals  Ashtead Technology

Poor diversification

The 3 months correlation between Faron and Ashtead is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Ashtead Technology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ashtead Technology and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Ashtead Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ashtead Technology has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Ashtead Technology go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Ashtead Technology

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to under-perform the Ashtead Technology. In addition to that, Faron Pharmaceuticals is 1.4 times more volatile than Ashtead Technology Holdings. It trades about -0.09 of its total potential returns per unit of risk. Ashtead Technology Holdings is currently generating about -0.03 per unit of volatility. If you would invest  58,200  in Ashtead Technology Holdings on September 25, 2024 and sell it today you would lose (4,600) from holding Ashtead Technology Holdings or give up 7.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Faron Pharmaceuticals Oy  vs.  Ashtead Technology Holdings

Faron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Ashtead Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ashtead Technology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ashtead Technology is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Faron Pharmaceuticals and Ashtead Technology

The main advantage of trading using opposite Faron Pharmaceuticals and Ashtead Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Ashtead Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ashtead Technology will offset losses from the drop in Ashtead Technology's long position.

The idea behind Faron Pharmaceuticals Oy and Ashtead Technology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.